INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
23/01/2026
Voltar para busca
Dado oficial do USPTO
ADVANCED ONCOTHERAPY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
24/01/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9, 10, 44
Data de depósito
26/07/2017
Data de registro
06/11/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/05/2025
Última transação
24/01/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
84
Localização do titular
London, GB
Examinador
FIORELLI, JOANNA ELISA-HOLGUI
Unidade examinadora
L50
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a stylized letter "A", within a stylized letter "O", appearing in blue. The stylized wording "ADVANCED ONCOTHERAPY" appears to the right in blue. The color white represents background or transparency and is not part of the mark.
Titulares e representantes
Titulares
ADVANCED ONCOTHERAPY PLC
Representantes
Jeffrey B. Sladkus, Esq. The Sladkus Law Group
Classificação técnica
Classes Nice
Classe 9Classe 10Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Computer hardware; computer softwarerecordedfor database management in the medical field; computer softwarerecordedfor an oncologic information system (OiS); computer softwarerecordedfor quality assurance in the field of radiotherapy; computer programsdownloadable software for database management in the medical field; computer programsdownloadable software for an oncologic information system (OiS); computer programsdownloadable software for radiotherapy quality assurance; particle accelerators; software for the guidance and control of particle accelerators; computer software for database management in the medical field; computer software for an oncologic information system (OiS); computer software for quality assurance in the field of radiotherapy; software for the guidance and control of proton radiotherapy equipment; software for the guidance and control of proton radiotherapy accelerators; software for the guidance and control of proton radiotherapy linear accelerators; software for the guidance and control of linear accelerators; software for the guidance and control of particle linear accelerators; computer software for radiotherapy treatment planning; computer hardware for radiotherapy treatment planning; software for proton dosimetry; software for guidance and control of radiotherapy treatment nozzlescollimators and degraders; software for guidance and control of radiotherapy of proton source apparatus
Classe 10
X-ray apparatus for medical purposes; X-ray tubes for medical purposes; apparatus and installations for the production of X-raysfor medical purposes; bedsspecially made for medical purposes; radiotherapy apparatus; radiological apparatus for medical purposes; particle accelerators for medical use; radiotherapy treatment apparatus; radiotherapy treatment planning apparatus; linear accelerators for medical use; proton linear accelerators for medical use; proton source and proton source apparatus for medical use; patient positioning systemsapparatus to stabilize and align the body during medical treatment; chairsspecially made for medical purposes; proton dosimetry apparatus; radiotherapy treatment nozzlescollimators and degraders; proton radiotherapy treatment nozzlescollimators and degraders; imaging systems for radiotherapy
Classe 44
Radiotherapy services; healthcareradiotherapy center services; medical clinic services; medical assistance; medical assistance in the field of proton therapy; medical services in the field of radiotherapy; radiotherapy treatment planning services; radiotherapy dosimetry services; imaging services for radiotherapy; medical services in the field of proton radiotherapy; proton radiotherapy treatment planning services; proton radiotherapy dosimetry services; imaging services for proton radiotherapy
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
C71T
CANCELLED SECTION 71
23/05/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/11/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/03/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/02/2019
FIMP
FINAL DISPOSITION PROCESSED
12/02/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/02/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
06/11/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/08/2018
PUBO
PUBLISHED FOR OPPOSITION
21/08/2018
GPNX
NOTIFICATION PROCESSED BY IB
17/08/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/08/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/08/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/08/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/07/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
13/07/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
13/07/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
13/07/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
13/07/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
31/05/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
31/05/2018
RFNT
REFUSAL PROCESSED BY IB
16/02/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
26/01/2018
RFRR
REFUSAL PROCESSED BY MPU
26/01/2018
MAFR
APPLICATION FILING RECEIPT MAILED
23/01/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/01/2018
CNRT
NON-FINAL ACTION WRITTEN
17/01/2018
DOCK
ASSIGNED TO EXAMINER
17/01/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/01/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/01/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ADVANCED ONCOTHERAPY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.